Company & Sponsor Intelligence

Second Affiliated Hospital, Zhejiang University, School of Medicine

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →
Indexed trials8
Recruiting3
Completed1
Countries1

Therapeutic footprint

alzheimersepilepsymigraine_headacheother_neurologyout_of_scopeparkinsons

Indexed studies

NCT04926987The Research of Human Cortex Cell Atlas
epilepsy · China
UNKNOWN
NCT05416476Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine
migraine_headache · China
PHASE3
NCT0435723618F-FDG PET Imaging Analysis of Antiepileptic Drug Response in BECTS
epilepsy · China
COMPLETED
NCT06992674The R-E-V-I-V-A-L Study
migraine_headache · China
PHASE2
NCT06013397Effectiveness of Ketogenic Diet in MELAS Syndrome
other_neurology · China
NA
NCT04213391Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
alzheimers · China
NA
NCT04642573The Metabolic Characteristics in Sublobar Areas of PRE Based on FDG-PET Study
out_of_scope · China
UNKNOWN
NCT07244640Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
parkinsons · China
RECRUITING

Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →